Alterations in the MA and NC domains modulate phosphoinositide-dependent plasma membrane localization of the Rous sarcoma virus gag protein

Journal of Virology

Volumn 87, Issue 6, 2013, Pages 3609-3615

  Nadaraia Hoke, Shorena ^a   Bann, Darrin V ^a   Lochmann, Timothy L ^a   Gudleski O'Regan, Nicole ^a   Parent, Leslie J ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; MUTANT PROTEIN; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELL NUCLEUS; CONTROLLED STUDY; INTRACELLULAR TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN TARGETING; ROUS SARCOMA ONCOVIRUS; VIRUS ASSEMBLY; VIRUS PARTICLE;

CELL MEMBRANE; GENE PRODUCTS, GAG; MUTANT PROTEINS; PHOSPHATIDYLINOSITOLS; PHOSPHOPROTEINS; PROTEIN TRANSPORT; ROUS SARCOMA VIRUS; VIRAL MATRIX PROTEINS; VIRUS ASSEMBLY;

EID: 84874678574     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03059-12     Document Type: Article

References (62)

1. Hamard-Peron E, Juillard F, Saad JS, Roy C, Roingeard P, Summers MF, Darlix JL, Picart C, Muriaux D. 2010. Targeting of murine leukemia virus gag to the plasma membrane is mediated by PI(4,5)P2/PS and a polybasic region in the matrix. J. Virol. 84:503-515.
2. Hansen M, Jelinek L, Whiting S, Barklis E. 1990. Transport and assembly of gag proteins into Moloney murine leukemia virus. J. Virol. 64:5306-5316.
3. Prchal J, Srb P, Hunter E, Ruml T, Hrabal R. 2012. The structure of myristoylated Mason-Pfizer monkey virus matrix protein and the role of phosphatidylinositol-(4,5)-bisphosphate in its membrane binding. J. Mol. Biol. 423:427-438.
4. Provitera P, Bouamr F, Murray D, Carter C, Scarlata S. 2000. Binding of equine infectious anemia virus matrix protein to membrane bilayers involves multiple interactions. J. Mol. Biol. 296:887-898.
5. Rein A, McClure MR, Rice NR, Luftig RB, Schultz AM. 1986. Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus. Proc. Natl. Acad. Sci. U. S. A. 83:7246-7250.
6. Rhee SS, Hunter E. 1991. Amino acid substitutions within the matrix protein of type D retroviruses affect assembly, transport and membrane association of a capsid. EMBO J. 10:535-546.
7. Stansell E, Apkarian R, Haubova S, Diehl WE, Tytler EM, Hunter E. 2007. Basic residues in the Mason-Pfizer monkey virus Gag matrix domain regulate intracellular trafficking and capsid-membrane interactions. J. Virol. 81:8977-8988.
8. Verderame MF, Nelle TD, Wills JW. 1996. The membrane-binding domain of the Rous sarcoma virus Gag protein. J. Virol. 70:2664-2668.
9. Zhou W, Parent LJ, Wills JW, Resh MD. 1994. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J. Virol. 68:2556-2569.
10. Chukkapalli V, Hogue IB, Boyko V, Hu WS, Ono A. 2008. Interaction between the human immunodeficiency virus type 1 Gag matrix domain and phosphatidylinositol-(4,5)-bisphosphate is essential for efficient Gag membrane binding. J. Virol. 82:2405-2417.
11. Chukkapalli V, Oh SJ, Ono A. 2010. Opposing mechanisms involving RNA and lipids regulate HIV-1 Gag membrane binding through the highly basic region of the matrix domain. Proc. Natl. Acad. Sci. U. S. A. 107:1600-1605.
12. Saad JS, Ablan SD, Ghanam RH, Kim A, Andrews K, Nagashima K, Soheilian F, Freed EO, Summers MF. 2008. Structure of the myristylated human immunodeficiency virus type 2 matrix protein and the role of phosphatidylinositol-(4,5)-bisphosphate in membrane targeting. J. Mol. Biol. 382:434-447.
13. Shkriabai N, Datta SA, Zhao Z, Hess S, Rein A, Kvaratskhelia M. 2006. Interactions of HIV-1 Gag with assembly cofactors. Biochemistry 45: 4077-4083.
14. Chan R, Uchil PD, Jin J, Shui G, Ott DE, Mothes W, Wenk MR. 2008. Retroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinositides. J. Virol. 82:11228-11238.
15. Saad JS, Miller J, Tai J, Kim A, Ghanam RH, Summers MF. 2006. Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly. Proc. Natl. Acad. Sci. U. S. A. 103:11364-11369.
16. Chen K, Bachtiar I, Piszczek G, Bouamr F, Carter C, Tjandra N. 2008. Solution NMR characterizations of oligomerization and dynamics of equine infectious anemia virus matrix protein and its interaction with PIP2. Biochemistry 47:1928-1937.
17. Fernandes F, Chen K, Ehrlich LS, Jin J, Chen MH, Medina GN, Symons M, Montelaro R, Donaldson J, Tjandra N, Carter CA. 2011. Phosphoinositides direct equine infectious anemia virus gag trafficking and release. Traffic 12:438-451.
18. Inlora J, Chukkapalli V, Derse D, Ono A. 2011. Gag localization and virus-like particle release mediated by the matrix domain of human Tlymphotropic virus type 1 Gag are less dependent on phosphatidylinositol-( 4,5)-bisphosphate than those mediated by the matrix domain of HIV-1 Gag. J. Virol. 85:3802-3810.
19. Palmiter RD, Gagnon J, Vogt VM, Ripley S, Eisenman RN. 1978. The NH2-terminal sequence of the avian oncovirus gag precursor polyprotein (Pr76gag). Virology 91:423-433.
20. Schultz AM, Henderson LE, Oroszlan S. 1988. Fatty acylation of proteins. Annu. Rev. Cell Biol. 4:611-647.
21. Butterfield-Gerson KL, Scheifele LZ, Ryan EP, Hopper AK, Parent LJ. 2006. Importin- family members mediate alpharetrovirus Gag nuclear entry via interactions with matrix and nucleocapsid. J. Virol. 80:1798-1806.
22. Scheifele LZ, Garbitt RA, Rhoads JD, Parent LJ. 2002. Nuclear entry and CRM1-dependent nuclear export of the Rous sarcoma virus Gag polyprotein. Proc. Natl. Acad. Sci. U. S. A. 99:3944-3949.
23. Scheifele LZ, Ryan EP, Parent LJ. 2005. Detailed mapping of the nuclear export signal in the Rous sarcoma virus Gag protein. J. Virol. 79:8732-8741.
24. McDonnell JM, Fushman D, Cahill SM, Zhou W, Wolven A, Wilson CB, Nelle TD, Resh MD, Wills J, Cowburn D. 1998. Solution structure and dynamics of the bioactive retroviral M domain from Rous sarcoma virus. J. Mol. Biol. 279:921-928.
25. Nelle TD, Wills JW. 1996. A large region within the Rous sarcoma virus matrix protein is dispensable for budding and infectivity. J. Virol. 70: 2269-2276.
26. Murray PS, Li Z, Wang J, Tang CL, Honig B, Murray D. 2005. Retroviral matrix domains share electrostatic homology: models for membrane binding function throughout the viral life cycle. Structure 13: 1521-1531.
27. Chan J, Dick RA, Vogt VM. 2011. Rous sarcoma virus Gag has no specific requirement for phosphatidylinositol-(4,5)-bisphosphate for plasma membrane association in vivo or for liposome interaction in vitro. J. Virol. 85:10851-10860.
28. Kisseleva MV, Cao L, Majerus PW. 2002. Phosphoinositide-specific inositol polyphosphate 5-phosphatase IV inhibits Akt/protein kinase B phosphorylation and leads to apoptotic cell death. J. Biol. Chem. 277: 6266-6272.
29. Brown FD, Rozelle AL, Yin HL, Balla T, Donaldson JG. 2001. Phosphatidylinositol 4,5-bisphosphate and Arf6-regulated membrane traffic. J. Cell Biol. 154:1007-1017.
30. Ono A, Ablan SD, Lockett SJ, Nagashima K, Freed EO. 2004. Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc. Natl. Acad. Sci. U. S. A. 101:14889-14894.
31. Shaner NC, Campbell RE, Steinbach PA, Giepmans BN, Palmer AE, Tsien RY. 2004. Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat. Biotechnol. 22:1567-1572.
32. Craven RC, Leure-duPree AE, Weldon RA, Jr, Wills JW. 1995. Genetic analysis of the major homology region of the Rous sarcoma virus Gag protein. J. Virol. 69:4213-4227.
33. Craven RC, Leure-duPree AE, Erdie CR, Wilson CB, Wills JW. 1993. Necessity of the spacer peptide between CA and NC in the Rous sarcoma virus Gag protein. J. Virol. 67:6246-6252.
34. Hermida-Matsumoto L, Resh MD. 2000. Localization of human immunodeficiency virus type 1 Gag and Env at the plasma membrane by confocal imaging. J. Virol. 74:8670-8679.
35. Callahan EM, Wills JW. 2003. Link between genome packaging and rate of budding for Rous sarcoma virus. J. Virol. 77:9388-9398.
36. Garbitt RA, Bone KR, Parent LJ. 2004. Insertion of a classical nuclear import signal into the matrix domain of the Rous sarcoma virus Gag protein interferes with virus replication. J. Virol. 78:13534-13542.
37. Weldon RA, Jr, Erdie CR, Oliver MG, Wills JW. 1990. Incorporation of chimeric Gag protein into retroviral particles. J. Virol. 64:4169-4179.
38. Weldon RA, Jr, Wills JW. 1993. Characterization of a small (25- kilodalton) derivative of the Rous sarcoma virus Gag protein competent for particle release. J. Virol. 67:5550-5561.
39. Johnson MC, Scobie HM, Ma YM, Vogt VM. 2002. Nucleic acidindependent retrovirus assembly can be driven by dimerization. J. Virol. 76:11177-11185.
40. Kenney SP, Lochmann TL, Schmid CL, Parent LJ. 2008. Intermolecular interactions between retroviral Gag proteins in the nucleus. J. Virol. 82: 683-691.
41. Parent LJ, Cairns TM, Albert JA, Wilson CB, Wills JW, Craven RC. 2000. RNA dimerization defect in a Rous sarcoma virus matrix mutant. J. Virol. 74:164-172.
42. Sigal CT, Zhou W, Buser CA, McLaughlin S, Resh MD. 1994. Aminoterminal basic residues of Src mediate membrane binding through electrostatic interaction with acidic phospholipids. Proc. Natl. Acad. Sci. U. S. A. 91:12253-12257.
43. Silverman L, Resh MD. 1992. Lysine residues form an integral component of a novel NH2-terminal membrane targeting motif for myristylated pp60v-src. J. Cell Biol. 119:415-425.
44. Zhou J, Bean RL, Vogt VM, Summers M. 2007. Solution structure of the Rous sarcoma virus nucleocapsid protein: muPsi RNA packaging signal complex. J. Mol. Biol. 365:453-467.
45. Zhou J, McAllen JK, Tailor Y, Summers MF. 2005. High affinity nucleocapsid protein binding to the muPsi RNA packaging signal of Rous sarcoma virus. J. Mol. Biol. 349:976-988.
46. Gudleski N, Flanagan JM, Ryan EP, Bewley MC, Parent LJ. 2010. Directionality of nucleocytoplasmic transport of the retroviral gag protein depends on sequential binding of karyopherins and viral RNA. Proc. Natl. Acad. Sci. U. S. A. 107:9358-9363.
47. Lochmann TL, Bann DV, Ryan EP, Beyer AR, Mao A, Cochrane A, Parent LJ. 2 October 2012. NC-mediated nucleolar localization of retroviral Gag proteins. Virus Res. [Epub ahead of print.] doi:10.1016/j.virusres .2012.09.011.
48. Federspiel MJ, Hughes SH. 1994. Effects of the gag region on genome stability: avian retroviral vectors that contain sequences from the Bryan strain of Rous sarcoma virus. Virology 203:211-220.
49. Datta SA, Heinrich F, Raghunandan S, Krueger S, Curtis JE, Rein A, Nanda H. 2011. HIV-1 Gag extension: conformational changes require simultaneous interaction with membrane and nucleic acid. J. Mol. Biol. 406:205-214.
50. Albi E, Viola Magni MP. 2004. The role of intranuclear lipids. Biol. Cell 96:657-667.
51. Barlow CA, Laishram RS, Anderson RA. 2010. Nuclear phosphoinositides: a signaling enigma wrapped in a compartmental conundrum. Trends Cell Biol. 20:25-35.
52. Boronenkov IV, Loijens JC, Umeda M, Anderson RA. 1998. Phosphoinositide signaling pathways in nuclei are associated with nuclear speckles containing pre-mRNA processing factors. Mol. Biol. Cell 9:3547-3560.
53. Bunce MW, Bergendahl K, Anderson RA. 2006. Nuclear PI(4,5)P(2): a new place for an old signal. Biochim. Biophys. Acta 1761:560-569.
54. Keune W, Bultsma Y, Sommer L, Jones D, Divecha N. 2011. Phosphoinositide signalling in the nucleus. Adv. Enzyme Regul. 51:91-99.
55. Mellman DL, Anderson RA. 2009. A novel gene expression pathway regulated by nuclear phosphoinositides. Adv. Enzyme Regul. 49:11-28.
56. Osborne SL, Thomas CL, Gschmeissner S, Schiavo G. 2001. Nuclear PtdIns(4,5)P2 assembles in a mitotically regulated particle involved in pre-mRNA splicing. J. Cell Sci. 114:2501-2511.
57. Toska E, Campbell HA, Shandilya J, Goodfellow SJ, Shore P, Medler KF, Roberts SG. 2012. Repression of transcription by WT1-BASP1 requires the myristoylation of BASP1 and the PIP2-dependent recruitment of histone deacetylase. Cell Rep. 2:462-469.
58. Ahn JY, Liu X, Cheng D, Peng J, Chan PK, Wade PA, Ye K. 2005. Nucleophosmin/B23, a nuclear PI(3,4,5)P(3) receptor, mediates the antiapoptotic actions of NGF by inhibiting CAD. Mol. Cell 18:435-445.
59. Bolte S, Cordelieres FP. 2006. A guided tour into subcellular colocalization analysis in light microscopy. J. Microsc. 224:213-232.
60. Schneider CA, Rasband WS, Eliceiri KW. 2012. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9:671-675.
61. Callahan EM, Wills JW. 2000. Repositioning basic residues in the M domain of the Rous sarcoma virus Gag protein. J. Virol. 74:11222-11229.
62. Garbitt RA, Albert JA, Kessler MD, Parent LJ. 2001. trans-Acting inhibition of genomic RNA dimerization by Rous sarcoma virus matrix mutants. J. Virol. 75:260-268.